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Abstract
Covalent multistep coating of poly(methylpentene), the membrane material in lung ventilators, by using a copper-free “click” ap-
proach with a modified cyclic RGD peptide, leads to a highly biocompatible poly(methylpentene) surface. The resulting modified
membrane preserves the required excellent gas-flow properties while being densely seeded with lung endothelial cells.
Introduction
Respiratory failures are a significant health-care problem with
several hundred thousand adult patients each year [1]. Besides
medical treatment, the use of mechanical ventilators that
provide breathing support while the lungs recover, is often
indispensable. This treatment is conducted when patients
respond inadequately to medical therapy. However, invasive
mechanical ventilation can damage the lungs physically by
overpressurizing lung tissue or due to inflammation. This may
lead to exacerbation of lung dysfunction or even to multiple-
organ failure [2,3]. The morbidity and mortality associated with
these problems still remains high.
Therefore, lung-support systems that perform the gas exchange
extracorporeal can provide an alternative. They are connected to
the patient via two cannulas in an arterio-venous circuit instead
of an endotracheal aditus. These devices are based on poly-
meric hollow-fiber membranes that serve as an interface
between blood and gas streams (Figure 1). The material must
allow adequate gas exchange thus providing CO2 removal and
O2 delivery for patients with respiratory or ventilatory failure.
The thermoplastic polymer poly(4-methylpent-1-ene) (TPX; 2)
complies with this requirement. It is currently used as a poly-
meric hollow-fiber membrane material in lung-support systems
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Figure 1: Schematic presentation of the artificial lung (A) and concept of membrane functionalization (B) with cyclic RGD 1b.
due to its low density of 0.835 g/cm3 and therefore its high gas
permeability, which allows an unhindered gas flow [4].
However, the artificial polymer surface leads to the formation
of blood clots, which prevent long-term gas exchange and
enforce the replacement of the device. This intervention is asso-
ciated with undesired risks for the patient, such as bleeding and
infections, as well as increased costs for the treatment.
Previously, experiments showed that the negative side effects of
the artificial surface can be significantly reduced by seeding
endothelial cells (ECs) onto a heparin/albumin-coated TPX
surface [5]. Although these endothelialized membranes showed
improved hemocompatibility, the cells were easily detached
from the membrane due to the water-soluble protein coating,
which is necessary for the cell attachment.
In this paper, we disclose a strategy to strongly attach ECs to
TPX 2 membranes by covalent functionalization of the chemi-
cally rather inert material with a cyclic peptide, containing the
RGD (arginine-glycine-asparagine) amino-acid sequence. We
chose cRGD pentapeptide 1b derived from lysine precursor 1a,
as cRGD’s intensively studied by the Kessler group [6-9] are
well-established cell-recognition motifs that can trigger inte-
grin-mediated cell adhesion [9]. Because of the high potential to
stimulate this, these RGD peptides have successfully been used
to generate biocompatible materials [10,11].
Conceptually, we planned to first functionalize the hydro-
carbon TPX 2 via UV-mediated nitrene insertion to form
polymer derivative 4 (Scheme 1) [12-14]. Therefore, nitrene
precursor 3 was modified with an oligo(ethylene glycol) linker,
which served as a spacer unit between the polymer and the
bioactive cRGD domain [15]. As the final coupling strategy, we
chose the Huisgen-type azide–alkyne-“click”-chemistry for
which connecting elements 5 and 6 were coupled to polymer
derivative 4. Classically, copper catalysts are required for these
kinds of 1,3-dipolar cycloadditions, but their potential cyto-
toxic properties limit the usability in biomedical applications
[16,17]. For overcoming this problem, several copper-free liga-
tion methods were developed. In this work we pursue both
options, i.e., the copper-mediated as well as the copper-free
version [18].
Results and Discussion
Plasma-activation and dip coating of TXP
We found that chemical modification of the rather inert TPX
membrane 2 was only possible in polar solvents because of the
hydrophilic nature of the pegylated precursor 3. Unfortunately,
dip coating of TPX 2 with a methanolic solution of nitrene
precursor 3, and then drying followed by UV irradiation (Hg
lamp, 254 nm) initially did not lead to surface modification. The
presence of F and N on the TPX membrane was not detectable
by XPS analysis. The photoinduced reaction of azide 3 with
cyclohexane served as a model reaction and provided the
expected tetrafluoro-substituted arylcyclohexyl amine in 47%
yield, proving the viability of the functionalization concept (see
Supporting Information File 1, section 2D). We assumed that
the hydrophobic nature of TPX 2 inhibited the bedabbling of the
polymer with linker 3. Therefore, TPX 2 was pretreated with
different types of plasma under conditions that resulted in lower
contact angles (see below). We chose atmospheric-pressure
plasma, which simplifies the procedure because the plasma
chamber does not need to be evacuated [19]. Importantly, the
plasma had to be optimized (with respect to the gas composi-
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Scheme 1: Functionalization of poly(4-methylpent-1-ene) (TPX) 2.
tion, time of treatment, distance of the plasma to the polymer
surface, and electronic parameters; see Supporting Information
File 1) in order not to damage the membrane by creating holes
or altering the shape of the material. This optimization finally
resulted in the use of a low-energy forming-gas plasma
(10% H2). The use of plasma for altering the surface properties
of polymers is well established. It can be expected that only the
surface is partially oxidized without affecting the integrity of
the material [20-22].
Next, the TPX membrane 2 (see below; bars are given in cm)
was treated with a solution of azide 3 as described above and
UV-irradiation gave covalently functionalized polymer 4. For
practicability reasons, flat TPX membranes instead of hollow
fibers were used.
Physicochemical analysis of modified TPX
foils
Analysis of all materials, including starting material TPX 2, was
achieved with different methods described in the following.
Contact-angle measurements showed an increase of about 60%
compared to the plasma-treated material, which is a diagnostic
for the coverage of the surface with linker 3. The IR spectrum
of 4 displayed carbonyl vibrations at 1640 cm−1. The IR vibra-
tion for the azido moiety at a wavelength of 2120 cm−1 was
absent, indicating that no adsorbed linker molecules were
present on the TPX surface (see Supporting Information File 1,
Figure S1). Additionally, UV served to prove successful CH
Figure 2: Analyses of functionalized TPX membranes with UV light at
312 nm; left: derivative 4; right: nonfunctionalized material as negative
control (scale bar equals 1 cm).
insertion of the nitrene moiety. Irradiation with UV light at
312 nm clearly showed absorption generated from the π-system
of the fluorinated phenyl ring (Figure 2). In contrast to this,
nonfunctionalized foils did not show any absorption.
X-ray photoelectron spectroscopy (XPS) analysis of functional-
ized TPX membrane 4 was used to determine the elements on
the polymer surface (Figure 3a). The strongest peak with a
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Figure 3: Analyses of functionalized TPX 4 by XPS spectroscopy using hν = 1250 eV; (a) overview, (b) F 1s core level, (c) N 1s core level.
kinetic energy of 967 eV was assigned to the 1s core level of
the carbon polymer backbone. In addition to carbon, oxygen
(O 1s at Ekin.= 720 eV) could be monitored on the surface,
which can be ascribed to the oxidative pretreatment with the
forming-gas plasma. Fluorine and nitrogen were also detected
on TPX derivative 4 (Figure 3b and 3c) by XPS measurements.
The fluorine peak (F 1s at Ekin.= 562 eV) was undoubtedly
related to the inserted linker because unmodified TPX
membranes did not show any absorption at 562 eV. Nitrogen
(N 1s at Ekin.= 846 eV) was already present on the surface after
plasma pretreatment but its percentage significantly increased
after the insertion process. Importantly, gas permeability tests
showed that the chemical modification of TPX did not alter its
excellent gas-flow properties (see Supporting Information
File 1, section 8). These analyses clearly demonstrate that
plasma treatment prior to the reaction with nitrene from
precursor 3 provides the hydrophilization of the polymer, which
is a prerequisite for successful dip-coat functionalization.
With these results on functionalized TPX 4 in hand we
continued the synthesis towards RGD functionalized TPX.
Therefore, simple washing protocols for facile workup were
applied because all reactions were performed on the polymer
surface. Thus, TPX derivative 4 was either coupled with alkyne
5 or with oxa-norbornadiene 6, by using classical coupling
chemistry, which resulted in polymers 7a and 7b, respectively
(Scheme 1). The alkyne-containing amino acid 5 was prepared
according to Brea et al. [15] Membrane 7a, synthesized from
polymer 4 and amino acid 5, was coupled with RGD peptide
1b, bearing an azido group, by the use of Huisgen-type “click”
chemistry (Scheme 2). cRGD pentapeptide 1b was prepared in
sufficient amounts by solution-phase chemistry [23]. Because of
the disadvantage associated with copper-mediated 1,3-cycload-
ditions of alkynes with azides in biological or biomedical appli-
cations we alternatively pursued a copper-free approach that
relied on the oxanorbornadiene strategy of Rutjes [24-28]. This
type of specific conjugation most likely proceeds by a 1,3-
dipolar cycloaddition/retro-Diels–Alder cascade. By incubating
oxanorbornadiene functionalized membranes 7b with cRGD
pentapeptide 1b the cycloaddition product 8a was formed in the
absence of any additives (Scheme 2). Prior to chemical reac-
tions carried out with modified TPX materials, all reactions
were first probed in solution (see Supporting Information File 1,
section 2D).
In order to analyze the outcome of 1,3-dipolar cycloadditions,
the model compound fluoresceinyl azide 9[29,30] was first
coupled to TPX derivatives 7a or 7b, under identical conditions
as described for cRGD peptide 1b. The resulting polymers 8c
and 8d were studied by determining the UV absorption peaks of
fluorescein between 400 and 600 nm (Figure 4). Absorption
maxima of fluorescein were located at 457 nm and 481 nm,
which can be ascribed to the presence of two isomeric forms
(lacton versus carboxylate) of fluorescein [31]. These measure-
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Scheme 2: Copper-catalyzed and copper-free azide–alkyne “click“ reaction between functionalized TPX membranes 7a or 7b and cRGD peptide 1b
or with fluorescein R5N3 9 for analytic purposes.
Figure 4: UV spectra of TPX 8c and 8d functionalized with fluorescein
revealing the efficiency of the 1,3-dipolar cycloaddition reactions on
modified TPX membranes. Continuous line: 8d; dotted line: 8c; dashed
line: substrate for Huisgen-type “click” reaction 7a.
ments clearly revealed the successful covalent functionalization
of TPX with fluorescein by 1,3-dipolar cycloaddition. The
copper-catalyzed method provided material 8c, which showed a
small but significant absorption maximum for fluorescein at
about 515 nm (dotted line versus dashed line) compared to
starting TPX 7a.
In contrast, the copper-free method led to intense fluorescein
staining (polymer 8d, continuous line) of the TPX membrane
with an increased factor for the absorption intensity of about 65
compared to 8c. This remarkable result may be rationalized if
one assumes that copper is not ideally distributed during the
course of the 1,3-dipolar cycloaddition reaction, as the pres-
ence of the heterogeneous TPX foils hampers continuous stir-
ring. When functionalized polymers 8c and 8d were washed by
soxhlet treatment (six hours in methanol) no change of the color
of the polymer membranes or the extracts was encountered. It
must be noted that neither TPX 2 nor functionalized analogues
4, 7a or 7b have an absorption maximum between 400 and
600 nm. In addition, plasma-treated unfunctionalized TPX
membrane 2, lacking an alkyne functionality, was treated with
azide 9 in order to determine the degree of physisorption of
fluorescein. Washing of the membrane, as routinely done in this
study, provided a material that did not reveal absorption
maxima between 440–600 nm. These results demonstrate that
the 1,3-dipolar cycloaddition protocols gave covalently linked
fluorescein–TPX membrane adducts.
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Endothelialization of TPX foils
Based on these promising results, we next tested the biological
properties of the new TPX materials 8a and 8b functionalized
with cRGD. Particularly, we investigated the growth of
endothelial cells (ECs) through integrin-mediated binding. ECs
were seeded at a density of 1 × 104 cells/cm2 on TPX
membranes 8a and 8b [5]. Adherence, growth and viability of
cells were monitored and quantified by calcein staining and
fluorescence imaging (see Supporting Information File 1,
section 2B).
Unmodified TPX membranes were used as negative control,
while albumin/heparin coated TPX, which are currently used in
clinical applications, were applied to monitor cell viability.
After 48 h cultivation the formation of a confluent endothelial
cell monolayer was observed on both the cRGD as well as
albumin/heparin-modified membranes. In contrast, no adherent
cells could be found on the unmodified membranes 2. To verify
that the observed effect is in fact only RGD-mediated,
membranes obtained during every functionalization step en
route to RGD-modified polymers 8a and 8b were also analyzed.
We found that seeding of cells onto the TPX membranes that
were treated with forming-gas plasma gave cell coverage
comparable to the control with heparin/albumin. This effect is
associated with increased hydrophilicity resulting from the
oxidative plasma conditioning on the surface [32]. The plasma-
mediated surface oxidation yields polar groups including
hydroxy groups, which rapidly vanish, a well-investigated aging
effect of plasma-treated materials. This process is an entropy-
initiated surface reorientation and it hampers direct chemical
modification of these oxidized surfaces [32]. Also our TPX
membrane 2 revealed this aging effect, as judged by changes of
the contact angles. Plasma treatment led to a lower angle (from
107°± 1° to 46° ± 7°), which increased to 70° ± 5° after one
week and further to 75° + 2° within two months, making
plasma-treated TPX 2 not suited for biomedical applications.
Once the TPX-membrane was functionalized with the PEG unit,
a significant reduction of the number of adhered cells was en-
countered (Figure 5c). This effect was even more pronounced
on TPX membranes 7a and 7b, where the ECs were either
exposed to the alkyne or the oxanorbornadiene-functionalized
surfaces, respectively (Figure 5d and 5f). This observation
correlates well with previous reports showing that cells do not
attach on PEGylated polymers as long as no additional growth
factors are present [33]. Finally, TPX surfaces 8a and 8b func-
tionalized with cRGD behaved differently regarding their cell-
adhesion properties (Figure 5e and 5g). These tests strongly
indicate that copper-catalyzed attachment of cRGD pentapep-
tides only provides a minor increase of biocompatibility, despite
the fact that the functionalized TPX 8a was excessively treated
with an aqueous solution of EDTA in order to remove all
copper traces adsorbed on the polymer. In contrast, TPX
membranes modified under copper-free “click” conditions were
homogenously covered with endothelial cells (Figure 5g). This
difference in surface coverage of ECs can be rationalized either
by (a) either the toxicity of the remaining copper traces or (b)
by the lower amount of surface-bound cRGD peptide on the
TPX membrane 8a (see Figure 4). It is worth noting that the
experiments were repeated eight times and revealed high repro-
ducibility of biological response for a given mode of chemical
modification.
Figure 5: Cell seeding onto TPX derivatives (scale bar equals 500 µm)
(a) 2 as control with heparin/albumin dip coating; (b) 2 treated with
forming-gas plasma; (c) functionalized TPX 4 with PEG; (d) functional-
ized TPX 7a with PEG and alkyne group; (e) functionalized TPX 8a
with cRGD (copper-catalyzed approach); (f) functionalized TPX 7b with
PEG and oxanorbonadiene group; (g) functionalized TPX 8b with
cRGD (copper-free approach).
Finally, we also repeated the whole synthetic sequence, but this
time using a PEG unit with a molar-mass distribution of
3000 g/mol instead of the defined PEG linker 3. This modified
material should reveal the impact of linker length on the effec-
tivity to grow ECs on TPX membranes. We found that this new
TPX membrane 8a showed reduced biological potency to bind
ECs. This observation is in accordance with studies by Beer et
Beilstein J. Org. Chem. 2013, 9, 270–277.
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al. who showed that virtually all RGD binding sites can be
reached by integrins, when the distance between the surface and
the RGD peptide amounts to 46 Å. Access by integrins again
decreases when the spacer is longer and likely folds in such a
way that RGDs become less surface-exposed [34].
Conclusion
In conclusion we developed a protocol for functionalizing poly-
hydrocarbons, here poly(4-methylpent-1-ene) (TPX), which are
important biomedical materials. For this purpose, nitrene inser-
tion proved to be a powerful way of achieving this functional-
ization, but only after the polymer had undergone plasma
pretreatment. Further derivatization was achieved that allowed
the introduction of cRGD pentapeptides by using either copper-
catalyzed or copper-free “click” protocols on TPX surfaces.
Finally, cRGD-functionalized TPX membrane surfaces showed
excellent biocompatibility regarding the adhesion of endothe-
lial cells. These studies pave the way for the development of
improved, extracorporeal oxygenators.
We believe that the combination of plasma treatment with
nitrene insertion is a protocol of general importance for the
functionalization of biomedical materials based on hydro-
carbon-derived polymers. The importance of developing strate-
gies for this kind of copper-free surface functionalization
reported here was recently also demonstrated by the Lahann
group [35]. We believe that the copper-free approach described
is of general importance and should be transferrable to
(bio)polymers, inorganic materials or to metals such as tita-
nium used in biomedical devices [36].
Supporting Information
Details on the synthesis and analyses of building blocks and
linkers, functionalization, biological evaluation and
descriptions of analyses of TPX materials based on XPS,
UV, IR and contact-angle measurements are found in
Supporting Information File 1.
Supporting Information File 1
Experimental and analytical data.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-9-33-S1.pdf]
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